Squamous Cell Carcinoma of Duodenum Secondary to Metastasis From Recurrent Head and Neck Cancer: A Case Report and Literature Review
- PMID: 37313071
- PMCID: PMC10259689
- DOI: 10.7759/cureus.38898
Squamous Cell Carcinoma of Duodenum Secondary to Metastasis From Recurrent Head and Neck Cancer: A Case Report and Literature Review
Abstract
This report describes a case involving the diagnosis and treatment of squamous cell carcinoma (SCC) of the duodenum, which was found to be a metastatic lesion originating from recurrent head and neck cancer (HNC) in a 74-year-old female patient. The patient had a past medical history of gastroesophageal reflux disease (GERD), tonsillar SCC, and recurrent HNC. She presented with symptoms of burning, tingling, and numbness of the throat and left side of the tongue. Upon examination with an esophagogastroduodenoscopy, an ulcerated hard area mass was detected in the third portion of the duodenum. Biopsy results confirmed the mass to be a metastatic poorly differentiated SCC. The incidence of head and neck squamous cell carcinoma (HNSCC) metastasis to the duodenum is rare, likely due to the unique anatomic location and the lack of lymphatic drainage in the area. The patient was treated with a combination of paclitaxel, carboplatin, and pembrolizumab. This case underscores the significance of considering unusual sites of metastasis in HNSCC patients and utilizing advanced imaging modalities and immunotherapy to detect and treat these locations effectively.
Keywords: head and neck oncology; metastatic squamous cell carcinoma; recurrent cancer; squamous cell carcinoma; tonsillar squamous cell carcinoma.
Copyright © 2023, Zaw et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Duodenal Squamous Cell Carcinoma From Metastatic Spread of Head and Neck Cancer: A Case Report.Cureus. 2024 Sep 20;16(9):e69826. doi: 10.7759/cureus.69826. eCollection 2024 Sep. Cureus. 2024. PMID: 39435199 Free PMC article.
-
A Unique Presentation of Concurrent Duodenal and Peritoneal Metastasis From Head and Neck Cancer.Cureus. 2021 Jan 22;13(1):e12859. doi: 10.7759/cureus.12859. Cureus. 2021. PMID: 33633890 Free PMC article.
-
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.Lancet Oncol. 2016 Jul;17(7):956-965. doi: 10.1016/S1470-2045(16)30066-3. Epub 2016 May 27. Lancet Oncol. 2016. PMID: 27247226 Clinical Trial.
-
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.Anticancer Agents Med Chem. 2019;19(3):290-303. doi: 10.2174/1871520618666180910092356. Anticancer Agents Med Chem. 2019. PMID: 30198439 Review.
-
Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.Neurosurg Focus. 2018 Jun;44(6):E11. doi: 10.3171/2018.2.FOCUS17761. Neurosurg Focus. 2018. PMID: 29852772 Review.
Cited by
-
Duodenal Squamous Cell Carcinoma From Metastatic Spread of Head and Neck Cancer: A Case Report.Cureus. 2024 Sep 20;16(9):e69826. doi: 10.7759/cureus.69826. eCollection 2024 Sep. Cureus. 2024. PMID: 39435199 Free PMC article.
References
-
- Distant metastases from head and neck squamous cell carcinomas. Calhoun KH, Fulmer P, Weiss R, Hokanson JA. Laryngoscope. 1994;104:1199–1205. - PubMed
-
- Risk factors for distant metastases in head and neck squamous cell carcinoma. Garavello W, Ciardo A, Spreafico R, Gaini RM. Arch Otolaryngol Head Neck Surg. 2006;132:762–766. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous